Did West’s Expanded Daikyo Distribution Deal Reshape West Pharmaceutical Services' (WST) GLP‑1 Component Investment Narrative?

Summary

West Pharmaceutical Services expanded its distribution deal with Daikyo, potentially reshaping the company's investment narrative in GLP-1 drug components. The expanded partnership signals West's growing presence in the high-demand GLP-1 market.